skip to main content
Show Results with:

Vulvodynia: Assessment and Treatment

Goldstein, Andrew T. et al.

The journal of sexual medicine. Volume 13:Issue 4 (2016); pp 572-590 -- Elsevier

Online access

  • Title:
    Vulvodynia: Assessment and Treatment
  • Author: Goldstein, Andrew T.;
    Pukall, Caroline F.;
    Brown, Candace;
    Bergeron, Sophie;
    Stein, Amy;
    Kellogg-Spadt, Susan
  • Found In: The journal of sexual medicine. Volume 13:Issue 4 (2016); pp 572-590
  • Journal Title: The journal of sexual medicine
  • Subjects: Sex--Periodicals; Sexual disorders--Periodicals; Sexual health--Periodicals; Vulvodynia--Sexual Pain--Vestibulodynia--Assessment--Diagnosis--Treatment; Dewey: 616.69005
  • Rights: Licensed
  • Publication Details: Elsevier
  • Abstract: Abstract Introduction Vulvodynia constitutes a highly prevalent form of sexual pain in women, and current information regarding its assessment and treatment is needed. Aim To update the scientific evidence published in 2010, from the Third International Consultation on Sexual Medicine, pertaining to the assessment and treatment of women's sexual pain. Methods An expert committee, as part of the Fourth International Consultation on Sexual Medicine, was comprised of researchers and clinicians from biological and social science disciplines for the review of the scientific evidence on the assessment and treatment of women's genital pain. Main Outcome Measures A review of assessment and treatment strategies involved in vulvodynia. Results We recommend the following treatments for the management of vulvodynia: psychological interventions, pelvic floor physical therapy, and vestibulectomy (for provoked vestibulodynia). We also support the use of multidisciplinary treatment approaches for the management of vulvodynia; however, more studies are needed to determine which components are most important. We recommend waiting for more empirical evidence before recommending alternative treatment options, anti-inflammatory agents, hormonal agents, and anticonvulsant medications. Although we do not recommend lidocaine, topical corticosteroids, or antidepressant medication for the management of vulvodynia, we suggest that capsaicin, botulinum toxin, and interferon be considered second-line avenues and that their recommendation be revisited once further research is conducted. Conclusion A comprehensive assessment is needed to understand the pain experience of women presenting with vulvodynia. In addition, treatment typically progresses from less invasive to more invasive, and several treatment options are worth pursuing.
  • Identifier: System Number: ETOCvdc_100053013999.0x000001; Journal ISSN: 1743-6095; doi/10.1016/j.jsxm.2016.01.020
  • Publication Date: 2016
  • Physical Description: Electronic
  • Shelfmark(s): 5064.060000
  • UIN: ETOCvdc_100053013999.0x000001

Searching Remote Databases, Please Wait